SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending due to community buzz surrounding a rumored COEP merger and ongoing speculation about Elon Musk's X platform integrating cryptocurrency payments, potentially leveraging DOGE. The community is actively debating whether this signals a broader return of meme coin season.

Moo Deng

MOODENG CRYPTO is attracting significant speculative interest and high trading volume, as the community rallies for another explosive pump, drawing comparisons to other top meme coins amid broader market anticipation for altcoin rallies.

Crocs, Inc. engages in the design, development, manufacture, worldwide marketing, sale, and distribution of lifestyle footwear and accessories. It operates through the Crocs Brand and HEYDUDE Brand segments. The company was founded by Scott Seamans, George B. Boedecker, Jr., and Lyndon V. Hanson III in 2002 and is headquartered in Broomfield, CO.

Crocs Inc

Crocs is trending as shares surged following stronger-than-anticipated earnings and an optimistic outlook, with the community highlighting robust international growth, substantial share buybacks, and planned cost savings, while many view the current valuation as compelling despite ongoing discussions around the HeyDude brand.

Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. It is pioneering research on nicotinamide adenine dinucleotide (NAD+). The company’s patent portfolio includes Nicotinamide Riboside (NR) and other NAD+ precursors, which are commercialized as the flagship ingredient Niagen. It operates through the following segments: Consumer Products, Ingredients, and Analytical Reference Standards and Services. The Consumer Products segment provides finished dietary supplement products that contain the firm’s proprietary ingredients directly to consumers as well as to distributors. The Ingredients segment supplies ingredients as raw materials to the manufacturers of consumer products. The Analytical Reference Standards and Services segment includes supply of phytochemical reference standards and other research and development services. The company was founded by Mark S. Germain and Frank L. Jaksch, Jr. in 1999 and is headquartered in Los Angeles, CA.

Niagen Bioscience Inc.

Niagen Bioscience (NAGE) is trending following strong Q3 earnings, a new share repurchase program, and a strategic partnership around its NOPARK Parkinson's trial, fueling investor excitement for potential pharmaceutical breakthroughs. The community is debating the trial's imminent results and their implications for the NAD+ healthy aging market, alongside recent regulatory shifts impacting competitor NMN.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu Crypto is trending with strong community conviction, driven by its consistent building of a permissionless brand that features real-world products and widespread IRL initiatives. Supporters are actively discussing its impressive resilience and upward price movement, making it a standout "conviction play" amid broader market turbulence.

Zcash is a privacy-focused cryptocurrency that uses trustless zero-knowledge proofs to enable fully encrypted transactions while maintaining blockchain transparency and security. It was the first cryptocurrency to implement zero-knowledge encryption for private peer-to-peer payments, addressing the fundamental privacy gap in traditional cryptocurrencies that expose transaction details publicly.   With a fixed supply of 21 million ZEC and a halving schedule similar to Bitcoin, Zcash allows users to prove transactions are valid without revealing sensitive information like wallet balances, transaction amounts, or participant identities, making it suitable for everyday payments, long-term savings, and cross-border money transfers where financial confidentiality matters.  The protocol operates on its own blockchain currently using Proof-of-Work consensus, though it's evolving toward Proof-of-Stake through the planned "Crosslink" upgrade to enhance security, scalability, and energy efficiency. Zcash employs trustless zero-knowledge proofs (Halo) within its Orchard shielded pool to verify transactions without revealing sender, receiver, or amount information.   Users can choose between transparent public transactions and shielded private transactions through Unified Addresses, which work with both types. The network is faster and cheaper than Bitcoin, with new blocks mined every 75 seconds and transaction fees typically just a fraction of a cent. Privacy adoption has surged in 2025, with over 30% of total ZEC supply now held in fully shielded pools.  Zcash was created by a group of scientists in 2013 who initially proposed Zerocoin as a privacy extension to Bitcoin before building a standalone protocol. The ecosystem operates with a self-funded development model where block rewards support independent teams through the Zcash Community Grants Committee and a new Coinholder-Controlled Fund.

Zcash

Zcash is trending as its core development team's transition from Electric Coin Company sparks debate: while many view it as a strategic move to a new entity for enhanced scalability and adoption, others express concern over perceived abandonment amid a broader crypto market downturn and a resurgent interest in privacy coins.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity Software is trending after a significant stock drop, driven by cautious Q1 guidance despite an earnings beat, and exacerbated by market fears regarding AI's potential to disrupt game development. Community sentiment is sharply divided, with some expressing deep frustration over the decline while others see it as an oversold opportunity for long-term growth or potential acquisition.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is actively discussed following its mixed Q4 earnings and a significant share sale by the CEO, sparking intense debate among investors about management's actions and the company's high debt load. While some see a buying opportunity and anticipate a brighter 2026 outlook with ongoing POSCO partnership talks, others remain highly skeptical of leadership and the company's financial health amid tariff uncertainties.

Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Energy Products, Chemical Products, and Specialty Products. The Upstream segment organizes the exploration of crude oil and natural gas. The Energy Products segment includes fuels, aromatics, and catalyst and licensing. The Chemical Products segment offers petrochemicals. The Specialty Products segment provides finished lubricants, basestocks and waxes, synthetics, and elastomers and resins. The company was founded by John D. Rockefeller in 1882 and is headquartered in Spring, TX.

Exxon Mobil Corp.

Exxon Mobil Corp

Exxon Mobil is drawing significant attention as escalating geopolitical tensions in the Middle East spark community debate about an imminent surge in oil prices, even as the stock trades near all-time highs following a strong earnings report and substantial share buyback plans, prompting some to anticipate a pullback.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian (TEAM) is trending due to a significant stock price decline, currently down notably this year, despite reporting solid earnings amidst broader software sector fears about AI disruption. The community is sharply divided, with some viewing the stock as an undervalued opportunity at current levels, while others fear continued downside given persistent AI threats and concerns over insider selling.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Growth Stocks To Research - February 14th

Prologis, Teledyne Technologies, and Ascendis Pharma A/S are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares in companies expected to...

Promising Growth Stocks To Add to Your Watchlist - February 13th

Prologis, Hercules Capital, Ascendis Pharma A/S, Teledyne Technologies, and Hamilton Lane are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are...

Ascendis Pharma A/S (NASDAQ:ASND) Announces Earnings Results, Misses Estimates By $0.58 EPS

Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) posted its earnings results on Wednesday. The biotechnology company reported ($0.64) EPS for the quarter, missing analysts' consensus estimates of...

Ascendis Pharma A/S (NASDAQ:ASND) Given Consensus Rating of "Buy" by Brokerages

Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) has been assigned a consensus recommendation of "Buy" from the seventeen ratings firms that are presently covering the stock, Marketbeat.com...

Best Growth Stocks To Research - February 12th

Prologis, Ascendis Pharma A/S, Teledyne Technologies, Tyra Biosciences, Hercules Capital, Hamilton Lane, and Trinity Capital are the seven Growth stocks to watch today, according to MarketBeat's...

Wedbush Issues Positive Forecast for Ascendis Pharma A/S (NASDAQ:ASND) Stock Price

Wedbush boosted their price target on shares of Ascendis Pharma A/S from $240.00 to $273.00 and gave the company an "outperform" rating in a report on Thursday...

Ascendis Pharma A/S Q4 Earnings Call Highlights

Ascendis Pharma A/S (NASDAQ:ASND) used its fourth-quarter 2025 earnings call to highlight continued commercial growth for its two marketed rare endocrine disease products, updates across its...

Growth Stocks To Follow Today - February 11th

Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, and Tyra Biosciences are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are...

Growth Stocks To Consider - February 9th

Prologis, Ascendis Pharma A/S, and Teledyne Technologies are the three Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies expected to...

Promising Growth Stocks To Consider - February 8th

Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, and Hercules Capital are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are...

Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes in its TransCon technologies to develop new therapies that address unmet medical needs. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau on September 21, 2006 and is headquartered in Hellerup, Denmark.

Ascendis Pharma A/S - ADR

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

Current Price	$216.32
Prev Close	$218.10
Open	$217.85
Dividend Yield	0.00%
50-Day Moving Average	$214.51
Beta	0.50
Avg. Volume	685,962.15
PE Ratio	-51.54

52-Week High	$242.00
52-Week Low	$124.06
Market Capitalization	$13.28B
EPS (Annual)	-$4.25
Price to Book	-69.44
Revenue Per Employee	N/A

ASND
Ascendis Pharma

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ASND News

ASNDAscendis Pharma